Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)

Market Cap	13.16B -18.9%
Revenue (ttm)	4.70B -8.4%
Net Income	765.01M -13.3%
EPS	1.15 -13.4%
Shares Out	663.61M
PE Ratio	17.21
Forward PE	15.37
Dividend	0.60 (3.07%)
Ex-Dividend Date	Sep 25, 2025

Volume	6,499,414
Average Volume	6,581,331
Open	19.45
Previous Close	19.53
Day's Range	19.44 - 19.86
52-Week Range	19.44 - 24.16
Beta	0.28
RSI	40.37
Earnings Date	Mar 7, 2026

About SHA:600529

Shandong Pharmaceutical Glass Co.Ltd engages in research and development, production, and sale of various pharmaceutical glass packaging products in China. The company offers moulded glass products, including amber glass containers, dropper bottles, infusion bottles, cosmetic bottles, tablet bottle, food glass, cobalt blue and green bottles, and black bottles, as well as moulded glass injection vial comprising type I/II/III. It also provides tubular glass products, such as glass tubes for pharma use, other tubular bottle with screw neck finish,...

• Industry: Packaging & Containers
• Sector: Consumer Discretionary
• Founded: 1970
• Employees: 7,116
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600529

Financial Performance

In 2024, SHA:600529's revenue was 5.13 billion, an increase of 2.87% compared to the previous year's 4.98 billion. Earnings were 942.99 million, an increase of 21.55%.